GCP
FPRX

GSA Capital Partners’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

GSA Capital Partners’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-56,422
Closed -$265K – 1765
2020
Q3 		$265K Buy
+56,422
New +$287K 0.04% 831
2020
Q2 		– Sell
-78,534
Closed -$178K – 1310
2020
Q1 		$178K Sell
78,534
-22,342
-22% -$94.8K 0.04% 792
2019
Q4 		$463K Buy
100,876
+73,250
+265% +$290K 0.05% 711
2019
Q3 		$107K Buy
27,626
+7,859
+40% +$43.1K 0.01% 1272
2019
Q2 		$119K Buy
+19,767
New +$189K 0.01% 1326
2018
Q4 		– Sell
-30,600
Closed -$426K – 1903
2018
Q3 		$426K Buy
+30,600
New +$455K 0.02% 1150
2018
Q2 		– Sell
-33,800
Closed -$581K – 2038
2018
Q1 		$581K Buy
+33,800
New +$659K 0.03% 986
2017
Q3 		– Sell
-27,500
Closed -$828K – 1966
2017
Q2 		$828K Sell
27,500
-16,600
-38% -$518K 0.05% 693
2017
Q1 		$1.59M Sell
44,100
-28,179
-39% -$1.24M 0.09% 371
2016
Q4 		$3.62M Buy
72,279
+1,279
+2% +$67.2K 0.22% 46
2016
Q3 		$3.73M Sell
71,000
-23,425
-25% -$1.12M 0.2% 57
2016
Q2 		$3.9M Buy
94,425
+3,563
+4% +$155K 0.22% 38
2016
Q1 		$3.69M Buy
90,862
+18,662
+26% +$641K 0.24% 35
2015
Q4 		$3M Buy
72,200
+7,086
+11% +$238K 0.15% 122
2015
Q3 		$1M Buy
65,114
+53,085
+441% +$1.14M 0.05% 625
2015
Q2 		$299K Sell
12,029
-26,867
-69% -$599K 0.01% 1624
2015
Q1 		$889K Buy
+38,896
New +$982K 0.04% 960

Other funds holding FPRX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GSA Capital Partners's FPRX Position: Q4 2020 in Review

GSA Capital Partners sold out of Five Prime Therapeutics, Inc. (FPRX) in Q4 2020, closing a stake of 56,422 shares — an estimated $265K sold.

GSA Capital Partners first reported a position in FPRX in Q1 2015 and held it in 17 quarters. The position peaked at $3.9M in Q2 2016. 125 funds tracked by Wall St. Rank hold FPRX as of Q4 2020.

  • GSA Capital Partners reported no remaining Five Prime Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
  • GSA Capital Partners sold 56,422 Five Prime Therapeutics, Inc. shares in Q4 2020, an estimated $265K.
  • GSA Capital Partners first reported a position in Five Prime Therapeutics, Inc. in Q1 2015 and held it in 17 quarters.
  • GSA Capital Partners's Five Prime Therapeutics, Inc. position peaked at $3.9M in Q2 2016.
  • 125 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q4 2020.

Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.